While the original mutations present in the HCC4006 cells (EGFR d746-750, TP53 Y205H) were also found in the adapted HCC4006rErlo0.5 cell line, no secondary mutation was found in the investigated tumor oncogenes (Figure 1). The gene discussed is EGFR; the disease is neoplasm.